Monitoring intestinal microbiota profile: A promising method for the ultraearly detection of colorectal cancer

Medical Hypotheses

Volumn 76, Issue 5, 2011, Pages 670-672

  Zhang, Ming Ming ^a   Cheng, Jing Qiu ^a   Xia, Lin ^a   Lu, Yan Rong ^a   Wu, Xiao Ting ^a  

^a SICHUAN UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BIFIDOBACTERIUM ADOLESCENTIS; BIFIDOBACTERIUM LONGUM; CANCER STAGING; COLORECTAL CANCER; DIAGNOSTIC PROCEDURE; EARLY DIAGNOSIS; HIGH RISK POPULATION; HUMAN; INTESTINE FLORA; MONITORING; NONHUMAN; PRECANCER; STREPTOCOCCUS BOVIS;

BIFIDOBACTERIUM; COLORECTAL NEOPLASMS; EARLY DETECTION OF CANCER; ENTEROCOCCUS FAECALIS; EUBACTERIUM; HUMANS; INTESTINES; MEDICAL ONCOLOGY; METAGENOME; MODELS, BIOLOGICAL; MODELS, THEORETICAL; NEOPLASM METASTASIS; RECURRENCE; RISK; STREPTOCOCCUS BOVIS;

BACTERIA (MICROORGANISMS);

EID: 79954423224     PISSN: 03069877     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mehy.2011.01.028     Document Type: Article

References (19)

1. Boyle P., Ferlay J. Cancer incidence and mortality in Europe, 2004. Ann Oncol 2005, 16(3):481-488.
2. Etzioni R., Urban N., Ramsey S., et al. The case for early detection. Nat Rev Cancer 2003, 3:243-252.
3. Cani P.D., Delzenne N.M. Gut microflora as a target for energy and metabolic homeostasis. Curr Opin Clin Nutr Metab Care 2007, 10(6):729-734.
4. Tjalsma H., Schöller-Guinard M., Lasonder E., Ruers T.J., Willems H.L., Swinkels D.W. Profiling the humoral immune response in colon cancer patients: diagnostic antigens from Streptococcus bovis. Int J Cancer 2006, 119(9):2127-2135.
5. Forchielli M.L., Walker W.A. The role of gut-associated lymphoid tissues and mucosal defence. Br J Nutr 2005, 93(Suppl. 1):S41-S48.
6. Sherman P.M., Cabana M., Gibson G.R., et al. Potential roles and clinical utility of prebiotics in newborns, infants, and children: proceedings from a global prebiotic summit meeting, New York City, June 27-28, 2008. J Pediatr 2009, 155(5):S61-S70.
7. Ogra P.L., Welliver R.C. Effects of early environment on mucosal immunologic homeostasis, subsequent immune responses and disease outcome. Nestle Nutr Workshop Ser Pediatr Program 2008, 61:145-181.
8. Frank D.N., St Amand A.L., Feldman R.A., Boedeker E.C., Harpaz N., Pace N.R. Molecular-phylogenetic characterization of microbial community imbalances in human inflammatory bowel diseases. Proc Natl Acad Sci U S A 2007, 104(34):13780-13785.
9. Neish A.S. Microbes in gastrointestinal health and disease. Gastroenterology 2009, 136:65-80.
10. Yang L., Pei Z. Bacteria, inflammation, and colon cancer. World J Gastroenterol 2006, 12(42):6741-6746.
11. Ohara T., Yoshino K., Kitajima M. Pre- and probiotics increase host-cell immunological competence, improve bowel movement, and prevent the onset of colon cancer - an analysis based on movements of intestinal microbiota. Rinsho Byori 2009, 57(6):533-541.
12. Kim Y., Lee D., Kim D., et al. Inhibition of proliferation in colon cancer cell lines and harmful enzyme activity of colon bacteria by Bifidobacterium adolescentis SPM0212. Arch Pharm Res 2008, 31(4):468-473.
13. Kawano A., Ishikawa H., Nakamura T., Kono K. Evaluation of epidemiological studies of intestinal bacteria that affected occurrence of colorectal cancer: studies of prevention of colorectal tumors by dairy products and lactic acid bacteria. Nippon Eiseigaku Zasshi 2010, 65(3):422-446.
14. Kumar M., Kumar A., Nagpal R., et al. Cancer-preventing attributes of probiotics: an update. Int J Food Sci Nutr 2010, 61(5):473-496.
15. Balamurugan R., Rajendiran E., George S., Samuel G.V., Ramakrishna B.S. Real-time polymerase chain reaction quantification of specific butyrate-producing bacteria, Desulfovibrio and Enterococcus faecalis in the feces of patients with colorectal cancer. J Gastroenterol Hepatol 2008, 23(8 Pt 1):1298-1303.
16. Boleij A., Roelofs R., Schaeps R.M., et al. Increased exposure to bacterial antigen RpL7/L12 in early stage colorectal cancer patients. Cancer 2010, 116(17):4014-4022.
17. Scanlan P.D., Shanahan F., Clune Y., et al. Culture-independent analysis of the gut microbiota in colorectal cancer and polyposis. Environ Microbiol 2008, 10(3):789-798.
18. O'Keefe S.J., Ou J., Aufreiter S., et al. Products of the colonic microbiota mediate the effects of diet on colon cancer risk. J Nutr 2009, 139(11):2044-2048.
19. Gueimonde M., Ouwehand A., Huhtinen H., Salminen E., Salminen S. Qualitative and quantitative analyses of the bifidobacterial microbiota in the colonic mucosa of patients with colorectal cancer, diverticulitis and inflammatory bowel disease. World J Gastroenterol 2007, 13(29):3985-3989.